N-terminal RASSF family (RASSF7-RASSF10): A mini review

Epigenetics

Volumn 6, Issue 3, 2011, Pages 284-292

  Underhill Day, Nicholas ^a   Hill, Victoria ^a   Latif, Farida ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cancer; Epigenetic; N terminal RASSF; RAS; Tumor suppressor

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; RAS ASSOCIATION DOMAIN FAMILY PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 10; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 7; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 8; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 9; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CENTROSOME; CHROMOSOMAL LOCALIZATION; CHROMOSOME 12; CPG ISLAND; CYTOSKELETON; DNA METHYLATION; EPIGENETICS; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE STRUCTURE; HUMAN; MICROTUBULE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 79952408564     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.3.14108     Document Type: Review

References (48)

1. Ponting CP, Benjamin DR. A novel family of Rasbinding domains. Trends Biochem Sci 1996; 21:422-5.
2. Saucedo LJ, Edgar BA. Filling out the Hippo pathway. Nat Rev Mol Cell Biol 2007; 8:613-21.
3. Newton AC. Protein kinase C: Poised to signal. Am J Physiol Endocrinol Metab 2010; 298:395-402.
4. Sherwood V, Manbodh R, Sheppard C, Chalmers AD. RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis. Mol Biol Cell 2008; 19:1772-82.
5. Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005; 65:3497-508.
6. Avruch J, Xavier R, Bardeesy N, Zhang XF, Praskova M, Zhou D, et al. Rassf family of tumor suppressor polypeptides. J Biol Chem 2009; 284:11001-5.
7. Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Bba-Rev Cancer 2009; 1796:114-28.
8. Weitzel JN, Kasperczyk A, Mohan C, Krontiris TG. The HRAS1 gene cluster: Two upstream regions recognizing transcripts and a third encoding a gene with a leucine zipper domain. Genomics 1992; 14:309-19.
9. Recino A, Sherwood V, Flaxman A, Cooper WN, Latif F, Ward A, et al. Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis. Biochem J 2010; 430:207-13.
10. Brandt R, Grutzmann R, Bauer A, Jesnowski R, Ringel J, Lohr M, et al. DNA microarray analysis of pancreatic malignancies. Pancreatology 2004; 4:587-97.
11. Friess H, Ding J, Kleeff J, Fenkell L, Rosinski JA, Guweidhi A, et al. Microarray-based identification of differentially expressed growth- and metastasisassociated genes in pancreatic cancer. Cell Mol Life Sci 2003; 60:1180-99.
12. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK, Giordano TJ, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63:2649-57.
13. Lowe AW, Olsen M, Hao Y, Lee SP, Taek Lee K, Chen X, et al. Gene expression patterns in pancreatic tumors, cells and tissues. PLoS One 2007; 2:e323.
14. Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, Kust GA, et al. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol 2001; 83:177-85.
15. Tan DS, Lambros MB, Rayter S, Natrajan R, Vatcheva R, Gao Q, et al. PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clin Cancer Res 2009; 15:2269-80.
16. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, et al. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008; 14:1340-8.
17. Liang GP, Su YY, Chen J, Yang ZC, Liu YS, Luo XD. Analysis of the early adaptive response of endothelial cells to hypoxia via a long serial analysis of gene expression. Biochem Biophys Res Commun 2009; 384:415-9.
18. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, Black DJ, Mahadevappa M, Swisher EM, et al. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 2002; 99:7560-5.
19. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008; 135:1311-23.
20. Goshima G, Wollman R, Goodwin SS, Zhang N, Scholey JM, Vale RD, et al. Genes required for mitotic spindle assembly in Drosophila S2 cells. Science 2007; 316:417-21.
21. Morris JA, Kandpal G, Ma L, Austin CP. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mol Genet 2003; 12:1591-608.
22. Tsang HT, Connell JW, Brown SE, Thompson A, Reid E, Sanderson CM. A systematic analysis of human CHMP protein interactions: Additional MIT domaincontaining proteins bind to multiple components of the human ESCRT III complex. Genomics 2006; 88:333-46.
23. Yasui S, Tsuzaki K, Ninomiya H, Floricel F, Asano Y, Maki H, et al. The TSC1 gene product hamartin interacts with NADE. Mol Cell Neurosci 2007; 35:100-8.
24. Debeer P, Schoenmakers EF, Thoelen R, Holvoet M, Kuittinen T, Fabry G, et al. Physical map of a 1.5 mb region on 12p11.2 harbouring a synpolydactyly associated chromosomal breakpoint. Eur J Hum Genet 2000; 8:561-70.
25. Debeer P, Schoenmakers EF, Twal WO, Argraves WS, De Smet L, Fryns JP, et al. The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly. J Med Genet 2002; 39:98-104.
26. Falvella FS, Spinola M, Manenti G, Conti B, Pastorino U, Skaug V, et al. Common polymorphisms in D12S1034 flanking genes RASSF8 and BHLHB3 are not associated with lung adenocarcinoma risk. Lung Cancer 2007; 56:1-7.
27. Lock FE, Underhill-Day N, Dunwell T, Matallanas D, Cooper W, Hesson L, et al. The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NFkappaB signaling pathways. Oncogene 2010; 29:4307-16.
28. Hesson LB, Dunwell TL, Cooper WN, Catchpoole D, Brini AT, Chiaramonte R, et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol Cancer 2009; 8:42.
29. Yanagitani N, Kohno T, Sunaga N, Kunitoh H, Tamura T, Tsuchiya S, et al. Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1. Carcinogenesis 2002; 23:1177-83.
30. Gariboldi M, Manenti G, Canzian F, Falvella FS, Radice MT, Pierotti MA, et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat Genet 1993; 3:132-6.
31. Falvella FS, Manenti G, Spinola M, Pignatiello C, Conti B, Pastorino U, et al. Identification of RASSF8 as a candidate lung tumor suppressor gene. Oncogene 2006; 25:3934-8.
32. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, et al. Downregulation of stem cell genes, including those in a 200 kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006; 66:820-7.
33. Weiser KC, Liu B, Hansen GM, Skapura D, Hentges KE, Yarlagadda S, et al. Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma. Mamm Genome 2007; 18:709-22.
34. Rykova E, Skvortsova TE, Hoffmann AL, Tamkovich SN, Starikov AV, Bryzgunova OE, et al. Breast cancer diagnostics based on extracellular DNA and RNA circulating in blood. Biomed Khim 2008; 54:94-103.
35. Langton PF, Colombani J, Chan EH, Wepf A, Gstaiger M, Tapon N. The dASPP-dRASSF8 complex regulates cell-cell adhesion during Drosophila retinal morphogenesis. Curr Biol 2009; 19:1969-78.
36. Eckfeldt CE, Mendenhall EM, Flynn CM, Wang TF, Pickart MA, Grindle SM, et al. Functional analysis of human hematopoietic stem cell gene expression using zebrafish. PLoS Biol 2005; 3:e254.
37. Downward J. Cancer: A tumour gene's fatal flaws. Nature 2009; 462:44-5.
38. Katoh Y, Katoh M. Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med 2009; 9:873-86.
39. Jin J, Smith FD, Stark C, Wells CD, Fawcett JP, Kulkarni S, et al. Proteomic, functional and domainbased analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 2004; 14:1436-50.
40. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005; 437:1173-8.
41. Alam MR, Caldwell BD, Johnson RC, Darlington DN, Mains RE, Eipper BA. Novel proteins that interact with the COOH-terminal cytosolic routing determinants of an integral membrane peptide-processing enzyme. J Biol Chem 1996; 271:28636-40.
42. Chen L, Johnson RC, Milgram SL. P-CIP1, a novel protein that interacts with the cytosolic domain of peptidylglycine alpha-amidating monooxygenase, is associated with endosomes. J Biol Chem 1998; 273:33524-32.
43. Rodriguez-Viciana P, Sabatier C, McCormick F. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 2004; 24:4943-54.
44. Schagdarsurengin U, Richter AM, Wohler C, Dammann RH. Frequent epigenetic inactivation of RASSF10 in thyroid cancer. Epigenetics 2009; 4:571-6.
45. Hill VK, Underhill-Day N, Krex D, Robel K, Sangan CB, Summersgill HR, et al. Epigenetic inactivation of the RASSF10 candidate tumour suppressor gene is a frequent and early event in gliomagenesis. Oncogene 2011; 30:978-89.
46. Reeves N, Posakony JW. Genetic programs activated by proneural proteins in the developing Drosophila PNS. Dev Cell 2005; 8:413-25.
47. Nybakken K, Vokes SA, Lin TY, McMahon AP, Perrimon N. A genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway. Nat Genet 2005; 37:1323-32.
48. Sherwood V, Recino A, Jeffries A, Ward A, Chalmers AD. The N-terminal RASSF family: A new group of Ras-association-domain-containing proteins, with emerging links to cancer formation. Biochem J 2009; 425:303-11.